SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-049800
Filing Date
2021-08-04
Accepted
2021-08-04 19:55:58
Documents
1
Period of Report
2021-08-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3915
  Complete submission text file 0001209191-21-049800.txt   5620
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Issuer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address ONE KENDALL SQUARE, BUILDING 200 SUITE 2203 CAMBRIDGE MA 02139
Business Address
Yea Christopher (Reporting) CIK: 0001691102 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36830 | Film No.: 211145789